Spots Global Cancer Trial Database for Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
Official Title: Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
Study ID: NCT03157856
Conditions
Interventions
Study Description
Brief Summary: In this study, we aim to evaluate the feasibility of anti-PSMA labelling to detect post-operative prostatic tissues by two ex vivo fluorescence techniques. We will evaluate the feasibility and detection of anti-PSMA labelling by: 1. / the FEMTO-ST institute medical device, 2. / the confocal microscope that will be used to measure fluorescence spectra of biological samples.
Detailed Description: For this protocol, 12 patients will be included.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Grenoble Alpes University Hospital - Urology department, Grenoble, , France
Grenoble Alpes University Hospital, Grenoble, , France
Contact Details
Name: Jean Luc Descotes, MD, PhD
Affiliation: Grenoble Alpes University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
